The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 29, 2020

Filed:

Oct. 19, 2017
Applicant:

Regents of the University of Minnesota, St. Paul, MN (US);

Inventors:

Gregory Frederick Molnar, St. Paul, MN (US);

Luke Johnson, St. Paul, MN (US);

David Escobar Sanabria, St. Paul, MN (US);

Edward Mark Bello, II, St. Paul, MN (US);

Jerrold L. Vitek, St. Paul, MN (US);

Matthew D. Johnson, St. Paul, MN (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2006.01); A61B 5/00 (2006.01); A61N 1/372 (2006.01); A61B 5/0496 (2006.01); A61N 1/05 (2006.01); A61B 5/0488 (2006.01); G16H 50/20 (2018.01); G16H 20/30 (2018.01); G16H 40/63 (2018.01); A61N 7/00 (2006.01); A61N 2/00 (2006.01); A61N 1/20 (2006.01); A61B 5/0478 (2006.01); A61N 1/378 (2006.01);
U.S. Cl.
CPC ...
A61N 1/36139 (2013.01); A61B 5/0488 (2013.01); A61B 5/0496 (2013.01); A61B 5/4064 (2013.01); A61B 5/4806 (2013.01); A61B 5/4812 (2013.01); A61B 5/4836 (2013.01); A61B 5/6868 (2013.01); A61N 1/0534 (2013.01); A61N 1/36067 (2013.01); A61N 1/36078 (2013.01); A61N 1/37258 (2013.01); G16H 20/30 (2018.01); G16H 40/63 (2018.01); G16H 50/20 (2018.01); A61B 5/0478 (2013.01); A61B 5/4082 (2013.01); A61B 2503/40 (2013.01); A61B 2503/42 (2013.01); A61N 1/20 (2013.01); A61N 1/3787 (2013.01); A61N 1/37264 (2013.01); A61N 2/006 (2013.01); A61N 7/00 (2013.01); A61N 2007/0026 (2013.01);
Abstract

Described here is a deep brain stimulation ('DBS') approach that targets several relevant nodes within brain circuitry, while monitoring multiple symptoms for efficacy. This approach to multi-symptom monitoring and stimulation therapy may be used as an extra stimulation setting in extant DBS devices, particularly those equipped for both stimulation and sensing. The therapeutic efficacy of DBS devices is extended by optimizing them for multiple symptoms (such as sleep disturbance in addition to movement disorders), thus increasing quality of life for patients.


Find Patent Forward Citations

Loading…